Internal Medicine, Nephrology · San Antonio, TX
NPI
1093951238
Since 2008
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
215 N San Saba Ste 301
San Antonio, TX, 78207
Phone (210) 212-8622
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
1,486 services
Medicare patients, 2024
403
Average age 72
Drug cost, 2024
$401K
1,348 prescriptions
Company payments, 2025
$1,959
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shirin Sharma was code 99233 (hospital e&m - subsequent), 657 times for 201 patients. In total Shirin Sharma billed 1,486 services in 22 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 657 | 201 | $89.95 | $59K |
| 99232 Hospital E&M - Subsequent | Facility | 220 | 87 | $59.50 | $13K |
| 99223 Hospital E&M - Initial | Facility | 133 | 122 | $127.30 | $17K |
| 99215 Office E&M - Established | Office | 96 | 58 | $109.12 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 71 | 50 | $12.55 | $891 |
| 90960 ESRD Related Services (not dialysis) | Office | 58 | 17 | $257.38 | $15K |
| 99214 Office E&M - Established | Office | 49 | 44 | $81.66 | $4,001 |
| 90961 ESRD Related Services (not dialysis) | Office | 43 | 17 | $219.85 | $9,454 |
| 90935 Hemodialysis | Facility | 22 | 17 | $53.77 | $1,183 |
| 99291 Critical Care E&M | Facility | 21 | 13 | $154.24 | $3,239 |
By year: 2022 $157K for 1,799 services; 2023 $120K for 1,282 services; 2024 $145K for 1,486 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shirin Sharma prescribed most often to Medicare patients was Furosemide, with 140 prescriptions and refills. In total Shirin Sharma wrote 1,348 Medicare prescriptions that cost $401K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 140 | 339 | 51 | $793 |
| Rayaldee Calcifediol | 139 | 139 | 20 | $189K |
| Farxiga Dapagliflozin Propanediol | 129 | 238 | 32 | $132K |
| Nifedipine Er Nifedipine | 103 | 181 | 29 | $1,680 |
| Tamsulosin Hcl Generic | 71 | 191 | 24 | $769 |
| Ciprofloxacin Hcl Generic | 53 | 53 | 41 | $295 |
| Allopurinol Generic | 50 | 148 | 22 | $305 |
| Bumetanide Generic | 49 | 77 | Under 11 | $2,867 |
| Carvedilol Generic | 35 | 75 | 14 | $335 |
| Calcium Acetate Generic | 34 | 54 | 12 | $2,935 |
| Sevelamer Carbonate Generic | 32 | 52 | 17 | $4,449 |
| Amlodipine Besylate Generic | 31 | 89 | 11 | $227 |
| Lisinopril Generic | 30 | 80 | 14 | $172 |
| Prednisone Generic | 27 | 74 | Under 11 | $191 |
| Losartan Potassium Generic | 26 | 72 | 14 | $216 |
Brand drugs: 371 claims; generic drugs: 977 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shirin Sharma $1,959 ($1,959 in general payments such as food, travel and fees) from 17 companies. The largest payer was OPKO Pharmaceuticals, LLC with $338.
| Company | Payments | Amount |
|---|---|---|
| OPKO Pharmaceuticals, LLC | 22 | $338 |
| Amgen Inc. AMGN | 9 | $244 |
| Corcept Therapeutics CORT | 2 | $233 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 8 | $216 |
| Travere Therapeutics, Inc. TVTX | 4 | $173 |
| Calliditas Therapeutics US Inc. | 6 | $168 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $115 |
| Ardelyx, Inc. ARDX | 4 | $93.55 |
| Akebia Therapeutics Inc AKBA | 4 | $83.12 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $65.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.